Pneumocystis jirovecii pneumonia (PJP) is a major opportunistic infection in people with HIV, particularly those with advanced immunosuppression. Its nonspecific clinical presentation can hinder diagnosis, especially in resource-limited settings. This study aimed to identify clinical and biochemical predictors of a positive P. jirovecii PCR result among people with HIV and suspected PJP. Methods: A retrospective observational study was conducted at RSUP Prof. dr. I.G.N.G. Ngoerah in 2024, 62 adult patients with HIV who were clinically suspected of having PJP were included. Clinical and laboratory data were extracted from electronic medical records. Bivariate analysis were conducted using the Chi-square and Mann–Whitney U tests, followed by multivariate logistic regression for variables with p<0.25 to determine independent predictors. Results: A positive P. jirovecii PCR test was identified in 24 (38.7%) HIV patients with suspected PJP. A positive PCR result was significantly associated with the absence of antiretroviral (ARV) treatment, an LDH level <500 U/l, and a CD4 count <100 cells/μl. A CD4 count <100 cells/μl remained a significant independent predictor following multivariate analysis (aOR=28.6; 95% CI: 3.4–250; p=0.002). Conclusions: A CD4 count <100 cells/μl was the strongest predictor of a positive P. jirovecii PCR result in people with HIV and suspected PJP. This essential marker is vital to identify individuals at higher risk of PJP and support timely diagnosis as well as therapeutic intervention in resource-limited settings.
Copyrights © 2026